that’s the thing mate, in the USA it is t a question of nice to have or must have, the insurance company just pays for it. There is no cost to the end user over there, the only hold up is that because there is no cost it has extra legal loopholes to pass through in order to demonstrate that it is of benefit to the patient and not just a way for the Dr to claim back extra cash per mum.
In Australia the question is a bit more murky… if it passes through the GC Health trials it kind of has to become part of Medicare payments as it will be part of a state government health offer.
the key question isn’t around must or nice to have, it’s just plainly and squarely one of execution and generation of revenue to support the new hires. Broward health was right there smack bang on the table ready to go pretty much straight after our EOFY and then….. what happened??? Stuck in legal limbo BECAUSE of the lack of cost to the patient…
It’s very frustrating indeed….
- Forums
- ASX - By Stock
- HMD
- Ann: Appendix 4D and Half Year Report
HMD
heramed limited
Add to My Watchlist
0.00%
!
1.2¢

Ann: Appendix 4D and Half Year Report, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.50M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.2¢ | $2.772K | 231.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 300000 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 1000000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 300000 | 0.011 |
2 | 1300098 | 0.010 |
2 | 1500000 | 0.009 |
3 | 437000 | 0.008 |
5 | 5038658 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 1000000 | 1 |
0.014 | 730840 | 2 |
0.015 | 796298 | 2 |
0.016 | 2197553 | 2 |
0.025 | 46598 | 1 |
Last trade - 11.54am 04/07/2025 (20 minute delay) ? |
Featured News
HMD (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online